Sacré, A., Barthélémy, P., Korenbaum, C., Burgy, M., Wolter, P., Dumez, H., Lerut, E., Loyson, T., Joniau, S., Oyen, R., Debruyne, P. R., Schöffski, P. and Beuselinck, B. (2016) “Prognostic factors in second-line targeted therapy for metastatic clear-cell renal cell carcinoma after progression on an anti-vascular endothelial growth factor receptor tyrosine kinase inhibitor”, Acta Oncologica, 55(3), pp. 329–340. doi: 10.3109/0284186X.2015.1099731.